Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Inivata

Inivata
2014 FOUNDED
PRIVATE STATUS
Series B LATEST DEAL TYPE
$52.4M LATEST DEAL AMOUNT
7 INVESTORS
Description

Provider of a cancer genomics monitoring platform intended to improve personalized healthcare in oncology. The company's platform unlocks essential genomic information from a simple blood test, focuses on harnessing the potential of circulating tumor DNA (ctDNA) analysis, enabling doctors to improve cancer testing and treatment.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Biotechnology
Primary Office
  • The Portway Building
  • Granta Park
  • Cambridge CB21 6GS
  • England, United Kingdom

+44 01223 000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Inivata’s full profile, request a free trial.

Inivata Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series B) 29-Mar-2019 $52.4M 00000 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 26-Jan-2016 000.00 000.00 0000 Completed Generating Revenue
1. Early Stage VC 23-Sep-2014 $6.55M $6.55M 000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Inivata Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 00,000,000 00.000000 00.0 00.0 00 00.0 00.000
Series B 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Deferred 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A 16,591,575 $0.000013 7% $2.5 $2.5 1x $2.5 37.04%
Preference 4,000,000 $0.000013 5% $1.32 $1.32 1x $1.32 8.93%
To view this company’s complete Cap Table, request access »

Inivata Competitors (52)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GeneCast Biotechnology Venture Capital-Backed Beijing, China 000.00 00000000000 000.00
00000000 Private Equity-Backed Seattle, WA 0000 000000000 0000
0000000000 0000000 Private Equity-Backed Vancouver, Canada 0000000000
0000000000 Venture Capital-Backed Jerusalem, Israel 00 000.00 000000&0
0000000000 0000000 Corporate Backed or Acquired Cambridge, MA 000 00000 00000000000
To view this company’s complete list of competitors, request access »

Inivata Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
RT Ventures Venture Capital Minority 000 0000 000000 0
IP Group Venture Capital Minority 000 0000 000000 0
Woodford Investment Management Asset Manager Minority 000 0000 000000 0
Cambridge Innovation Capital Venture Capital Minority 000 0000 000000 0
Cancer Research UK Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Inivata Executive Team (16)

Name Title Board
Seat
Contact
Info
Clive Morris MD Chief Executive Officer
Tim Shannon Chief Financial Officer
Jamie Platt Ph.D Chief Operating Officer
Charlie Kesinger Chief Information Officer
Nitzan Rosenfeld Ph.D Chief Scientific Officer, Co-Founder & Board Member

5 Former Executives

You’re viewing 5 of 16 executives. Get the full list »

Inivata Board Members (10)

Name Representing Role Since Contact
Info
Jeanne Bolger MD Johnson & Johnson Innovation - JJDC Board Member 000 0000
Jeffrey Buchalter Inivata Non-Executive Chairman 000 0000
Keith Blundy Ph.D Cancer Research UK Board Member 000 0000
Nitzan Rosenfeld Ph.D Inivata Chief Scientific Officer, Co-Founder & Board Member 000 0000
Patrick Terry Self Board Member 000 0000

3 Former Board Members

You’re viewing 5 of 10 board members. Get the full list »